Our Neuroregenerative Program was designed for people living with conditions like Parkinson’s, multiple sclerosis (MS), and essential tremors who wish to explore the use of ibogaine for these conditions. Using optimized loading doses followed by extended microdosing, the protocol targets regeneration and an improved quality of life in the long term, and can make the treatment more tolerable for older patients, or those who grapple with muscle spasticity and other physical limitations. This program is evolving in close relationship with ongoing Ambio-sponsored research.